Stamos Capital Partners, L.P. Gsk PLC Transaction History

Stamos Capital Partners, L.P.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	BUY	$40.23 - $47.74 $2.3 Million - $2.73 Million	57,200 Added 42.12%	193,000 $8.41 Million
Q4 2021 Feb 14, 2022	BUY	$38.88 - $45.31 $1.22 Million - $1.42 Million	31,410 Added 30.09%	135,800 $5.99 Million
Q2 2021 Aug 13, 2021	SELL	$36.52 - $41.46 $47,841 - $54,312	-1,310 Reduced 1.24%	104,390 $4.16 Million
Q4 2020 Feb 12, 2021	BUY	$34.07 - $39.94 $3.6 Million - $4.22 Million	105,700 New	105,700 $3.89 Million
Q2 2020 Aug 14, 2020	SELL	$37.87 - $43.58 $1.03 Million - $1.19 Million	-27,278 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$32.47 - $48.83 $885,716 - $1.33 Million	27,278 New	27,278 $1.03 Million
Q3 2019 Nov 14, 2019	SELL	$40.46 - $43.52 $242,760 - $261,120	-6,000 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$39.4 - $42.7 $275,800 - $298,900	-7,000 Reduced 53.85%	6,000 $243,000
Q1 2019 May 10, 2019	SELL	$38.57 - $42.69 $501,410 - $554,970	-13,000 Reduced 50.0%	13,000 $525,000
Q4 2018 Feb 14, 2019	BUY	$37.8 - $42.69 $982,799 - $1.11 Million	26,000 New	26,000 $993,000

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Stamos Capital Partners, L.P., based on Form 13F filings with the SEC.

Stay updated on Stamos Capital Partners, L.P. with notifications on news.